University of Nebraska - Lincoln

DigitalCommons@University of Nebraska - Lincoln
Biochemistry -- Faculty Publications

Biochemistry, Department of

11-2018

Combining Mass Spectrometry and NMR Improves Metabolite
Detection and Annotation
Fatema Bhinderwala
University of Nebraska - Lincoln, fbhinderwala2@unl.edu

Nishikant Wase
University of Nebraska-Lincoln, nishikant.wase@gmail.com

Concetta DiRusso
University of Nebraska - Lincoln, cdirusso2@unl.edu

Robert Powers
University of Nebraska - Lincoln, rpowers3@unl.edu

Follow this and additional works at: https://digitalcommons.unl.edu/biochemfacpub
Part of the Biochemistry Commons, Biotechnology Commons, and the Other Biochemistry, Biophysics,
and Structural Biology Commons

Bhinderwala, Fatema; Wase, Nishikant; DiRusso, Concetta; and Powers, Robert, "Combining Mass
Spectrometry and NMR Improves Metabolite Detection and Annotation" (2018). Biochemistry -- Faculty
Publications. 469.
https://digitalcommons.unl.edu/biochemfacpub/469

This Article is brought to you for free and open access by the Biochemistry, Department of at
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Biochemistry -- Faculty
Publications by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln.

HHS Public Access
Author manuscript
Author Manuscript

J Proteome Res. Author manuscript; available in PMC 2019 November 02.
Published in final edited form as:
J Proteome Res. 2018 November 02; 17(11): 4017–4022. doi:10.1021/acs.jproteome.8b00567.

Combining Mass Spectrometry and NMR Improves Metabolite
Detection and Annotation
Fatema Bhinderwala1,2, Nishikant Wase2, Concetta DiRusso2,3, Robert Powers1,3,*
1Department

of Chemistry, University of Nebraska-Lincoln, Lincoln, NE 68588-0304

2Department

of Biochemistry, University of Nebraska-Lincoln, Lincoln, NE 68588-0664

Author Manuscript

3Nebraska

Center for Integrated Biomolecular Communication

Abstract
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Despite inherent complementarity, nuclear magnetic resonance spectroscopy (NMR) and mass
spectrometry (MS) are routinely separately employed to characterize metabolomics samples. More
troubling is the erroneous view that metabolomics is better served by exclusively utilizing MS.
Instead, we demonstrate the importance of combining NMR and MS for metabolomics by using
small chemical compound-treatments of Chlamydomonas reinhardtii as an illustrative example. A
total of 102 metabolites were detected (82 by GC-MS, 20 by NMR and 22 by both techniques).
Out of these 47 metabolites of interest were identified, where 14 metabolites were uniquely
identified by NMR and 16 metabolites were uniquely identified by GC-MS. A total of 17
metabolites were identified by both NMR and GC-MS. In general, metabolites identified by both
techniques exhibited similar changes upon compound treatment. In effect, NMR identified key
metabolites that were missed by MS and enhanced the overall coverage of the oxidative pentose
phosphate pathway, Calvin cycle, tricarboxylic acid cycle and amino acid biosynthetic pathways
that informed on pathway activity in central carbon metabolism leading to fatty acid and complex
lipid synthesis. Our study emphasizes a prime advantage of combining multiple analytical
techniques - an improved detection and annotation of metabolites.
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Metabolomics is experiencing exponential growth1 and has made substantial contributions to
various research areas, such as nutrition, plant physiology, cellular metabolism, disease
diagnosis and biomarker detection, and drug discovery and development.2–45–6 To date,
metabolomics has primarily relied on the separate application of mass spectrometry (MS) or
nuclear magnetic resonance spectroscopy (NMR), but there are also notable examples of the
application of surface enhanced Raman spectroscopy and Fourier-transform infrared
spectroscopy (FTIR).7 Nevertheless, the vast majority of recently published metabolomics
studies are only making use of GC-MS or LC-MS despite prior contributions from NMR and
other analytical techniques.8 In 2017, only 5% of metabolomics manuscripts published in
PubMed described any form of a combined NMR and GC-MS approach to metabolomics
(Figure 1). This may be explained, in part, by an erroneous belief that mass spectrometry is
the optimal analytical technique for metabolomics. Unfortunately, this false perspective has
begun to negatively impact the field, and will likely limit the coverage of the metabolome,
potentially diminish the quality of research, and hamper progress. Instead, metabolomics
should seek to maximize (not limit) the number of analytical techniques used to characterize
the entirety of the metabolome. Moreover, the confidence and accuracy of metabolite
identification and quantification is improved by the application of multiple analytical
techniques. Thus, the goal of the field should be to accurately address scientific questions by
striving for the broadest coverage of the metabolome; not by focusing on the type of
instrumentation used.
NMR and MS are inherently complementary due to their distinct strengths and weaknesses.
This, in turn, leads to different sets of metabolites that are uniquely detected by NMR and

J Proteome Res. Author manuscript; available in PMC 2019 November 02.

Bhinderwala et al.

Page 3

Author Manuscript
Author Manuscript

MS. Accordingly, combining both NMR and MS will result in a greater coverage of the
metabolome. Simplistically, NMR detects the most abundant metabolites and MS detects the
metabolites that are readily ionizable. This arises from fundamental differences between
NMR and MS. For example, NMR requires minimal sample handling, but chromatography
is a necessary component of MS metabolomics because of the relatively narrow molecularweight distribution of the metabolome.9 Chromatography methods are plagued by nonuniform metabolite derivatization, incomplete column recovery, decomposition during
derivatization, ion-suppression due to the co-eluent matrix, and or misaligned retention times
to name a few.10–14 Similarly, small molecules exhibit variable thermal stability that may
lead to the loss of metabolites and the erroneous accumulation of degradation products at
temperatures routinely used for gas chromatography (GC).15 Conversely, NMR lacks the
sensitivity to detect metabolites in the sub-micromolar range (≥ 1 μM) and has limited
spectral resolution that often results in peak overlap.16 MS also has a higher resolution (~103
to 104) and dynamic range (~103 to 104) relative to NMR.

Author Manuscript

Ambiguous peak assignments are a common problem encountered by both NMR and MS.
This issue is attributed to limitations in the availability of reference spectra, insufficient
software and databases, and our incomplete knowledge of the metabolome. It is believed that
nearly all metabolomics investigations have at least one misidentified or unidentified
metabolite.17 Natural product chemistry has routinely employed protocols involving both
NMR and MS data to identify novel compounds, but the application of this combinatorial
approach has seen limited usage in metabolomics.18 Nevertheless, a few methods have
recently been described that combine NMR and MS to assign metabolites and identify
unknowns.19–21 Notably, the community has recognized that metabolomics needs to
continue to move in this direction.8, 21–26 There have also been a few recent examples that
highlight the utility and complementarity of combining 1D 1H NMR with direct injection or
LC/GC-MS experiments for metabolomics.27–28 Most of these examples are methodology
driven, are focused on improving statistical tools and modeling, or performed parallel, but
separate, sample analysis.29–31 In this regards, NMR is routinely only used as a supplement
to MS or in a secondary confirmatory role. Accordingly, the full impact of using NMR to
characterize a metabolomics sample is missed.
Current estimates suggest the size of the human metabolome is approximately 150,000
metabolites, but only upwards of a few hundred metabolites are typically identified in a
given metabolomics study.32 Combining MS with NMR and other analytical techniques is
necessary to move beyond this self-imposed limit.
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To address this need, a global metabolomics study was performed in a platform-unbiased
fashion to highlight the intrinsic benefits of combining NMR and MS. In this regard, NMR
and MS data were collected on a similar set of samples without complicating existing
workflows or requiring major protocol modifications. Accordingly, there were no serious
experimental barriers encountered that would prevent the metabolomics community from
adapting a combined NMR and MS approach as a standard for the field. As an illustrated
example, the metabolome of Chlamydomonas reinhardtii grown in tris-acetate phosphate
(TAP) media (13C2-acetate for NMR) was characterized by NMR and GC-MS. The cells
were also treated with two lipid accumulation modulators (WD30030 and WD10784) as
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described by Wase et al.33 The aqueous-extracted metabolomes from treated and untreated
cells were then compared to identify metabolic variations due to the compound treatments.
The eRah package was used to perform peak picking, retention time alignment and
metabolite library search for the GC-MS dataset.33–34 Similarly, NMRpipe35 and
NMRviewJ36 were used for processing and peak picking the NMR dataset and metabolite
assignments were performed using spectral databases.37 A schematic overview of the
workflow is shown in Figure 2A. Details of data handling, processing and analyses are
available as supplemental information.
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The complete 2D 1H-13C HSQC NMR spectra obtained from C. reinhardtii metabolome
extracts were used for non-supervised multivariate analyses to generate a principal
component analyses (PCA) scores plot with an associated dendrogram (Figure S-1A).
Statistical models were generated after the data was processed as a matrix to be standard
normal variate (SNV) normalized and unit variance scaled. The WD30030 and WD10784
treated cells formed distinct clusters separate from the untreated control. The dendrogram
generated from the Mahalanobis distances between each point in the PCA scores plot and
the resulting p-value between each node indicates a statistically significant (p < 0.05)
separation between each group. Similarly, metabolite assignments from the GC-MS spectral
dataset were obtained from the eRah package and identified using the GOLM database.38
The assigned metabolite peak areas were then imported as a matrix into MVAPACK to
obtain a comparable PCA scores plot and dendrogram as described above (Figure S-1B).39
A similar statistically significant group separation between the WD30030/WD10784 treated
cells and the untreated controls was obtained. Importantly, the NMR and GC-MS datasets
were successfully combined to generate a comparable multiblock (MB)-PCA model with a
corresponding dendrogram (Figure 2B).30 The MB-PCA model provides a single statistical
model for both datasets. In this manner, key metabolite differences between the treated and
untreated controls can be identified irrespective of the analytical method.
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Overall, 82 compounds were identified by GC-MS alone; 20 by NMR alone, and 22 were
common to both methods (Tables S-1 to S-3). Of these 102 detected metabolites, a total of
47 metabolites of interest were perturbed upon compound treatment (Table S-4). Thus, a
greater coverage of compound-induced changes in the C. reinhardtii metabolome was
obtained by combining the metabolite assignments from the NMR and GC-MS datasets.
Specifically, 14 unique metabolites were identified from the NMR analysis of 13C2-acetate
labeled C. reinhardtii cells that were significantly perturbed upon treatment with either
WD30030/WD10784. Metabolites were assigned using the Biological Magnetic Resonance
Bank (BMRB) metabolomics database.40 Similarly, 16 unique metabolites were identified
from the GC-MS spectra using the GOLM database. Furthermore, an additional 17
metabolites were identified by both NMR and GC-MS. In total, the metabolites comprise the
following metabolic pathways: oxidative pentose phosphate pathway, Calvin cycle,
tricarboxylic acid cycle and amino acid biosynthetic pathways. A summary of the C.
reinhardtii metabolic changes of interest resulting from treatment with WD30030/WD10784
is shown in Figure 3.
NMR and GC-MS identified nine glycolytic intermediates, where fructose, glycerol and
pyruvate were uniquely identified by NMR and fructose-6-phosphate was unique to GC-MS.
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All 20 amino acids were detected from the combined datasets, but asparagine, cysteine,
histidine, serine and tryptophan were only observed by GC-MS. Consequently, glycine,
lysine, methionine, and valine were unique to NMR. Tricarboxylic acid cycle and Calvin
cycle metabolites exhibited the most variation. Acetate, isocitrate, ketoglutarate, malate and
succinate were identified by NMR, but fumarate was limited to GC-MS. Ribulose and its
phosphate derivatives were exclusively assigned through GC-MS. Nucleotide and nucleoside
analogs were the metabolite group consistently observed by both techniques. Seven out of
the ten metabolites, 2-deoxy adenosine, adenosine, guanosine, hypoxanthine, inosine,
thymine, and xanthosine were observed by both NMR and GC-MS. Cytosine and uridine
were uniquely identified by NMR; whereas, uracil was only observed by GC-MS. A
complete list of metabolites identified by NMR and GC are provided in the supplemental
information (Tables S-1 to S-4).
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The complete set of 22 metabolites identified by both NMR and GC-MS including the 17
metabolites of interest depicted in Figure 3 were further evaluated for overall consistency
between the two methods. A correlation between the 22 common metabolites was evaluated
using Pearson correlation within the R environment (http://www.r-project.org) and the
resulting comparison is plotted in Figure 4. While there is significant scatter, the overall
trend is quite similar. It is important to note that only relative changes in metabolite
concentrations were compared. Furthermore, the GC-MS metabolomics analysis was
untargeted and lacked any metabolite-specific calibration. Conversely, the absolute
quantitation of metabolite concentration changes is an inherent strength of NMR. But, NMR
was only used to monitor the relative changes in metabolites derived from 13C2-acetate;
whereas, GC-MS captured total metabolite changes. Differences in the number of sample
processing steps may also impart unintended variations. Metabolite derivatization has been
identified as a major source of sample variation.10, 12, 14 Similarly, variable metabolite
stability during GC-MS data acquisition is another potential source of error.15 Finally, a
limited number of biological replicates will also contribute to a larger variance. We want to
emphasize that given these unavoidable discrepancies, and the limited number of sample
replicates, the observed correlation between the relative changes in metabolite concentration
is quite notable. Importantly, the overall trend (or direction) in metabolite concentration
change is preserved for the majority of metabolites despite the scatter in the magnitude of
these changes. Furthermore, a simple comparison of metabolite trends is probably the limit
of the data given the distinct and numerous sources of variance.

Author Manuscript

A pair-wise comparison between the 22 individual metabolites identified by both NMR and
GC-MS are plotted as line curves in Figure S2. Again, an acceptable level of consistency is
achieved in the pair-wise comparisons. A general agreement was also observed in the
relative changes between both compound treatments. Any observed discrepancies between
metabolite trends may be explained by the fact that GC-MS is capturing the total metabolite
change while NMR is only capturing the changes in metabolites derived from 13C2-acetate.
In this regards, both measurements are likely correct, but are simply observing different
aspects of the metabolome. Again, this highlights the inherent strength of combining both
NMR and MS. Conversely, if GC-MS observes a significantly lower metabolite
concentration relative to NMR, this is a likely an error in the GC-MS data due to a limited
thermal stability of the metabolite, variations in derivatization efficiency, and the multi-peak
J Proteome Res. Author manuscript; available in PMC 2019 November 02.
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phenomena.12–15 Additionally, given the fact that NMR routinely provides highly accurate
sample quantitation relative to MS, NMR is likely to provide the correct metabolite change
when the methods disagree (Figure S3).41
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Extensive, nearly complete, coverage of key metabolic pathways associated with lipid
accumulation was only achieved by combining NMR and GC-MS data. In effect, the NMR
data filled-in the metabolites that were missed by GC-MS. Importantly, the broader coverage
of the C. reinhardtii metabolome was able to provide a comprehensive view of the algae’s
response to a compound treatment. This level of detail is essential to further our
understanding of the mechanism of action of drug-leads, of drug resistance, and of disease
development and progression, among numerous other potential utilities. Achieving this level
of coverage of the metabolome requires employing multiple analytical techniques. This
viewpoint is consistent with some prior observations.8, 21–26 For example, Chen et al. noted
an improvement in biomarker identification by combining 1D 1H NMR and GC-MS for the
analysis of urine from patients with bipolar disorder.42 Another recent example highlighted
the use of 1D 1H NMR and GC-MS for the analysis of bronchial wash fluid to investigate
responsiveness to air pollution.43 Barding et al. have highlighted similar improvements in
coverage of the metabolome in molecular response of rice to stress.44 These studies were
able to combine multiple datasets to obtain a robust set of biomarkers, which further
emphasizes the benefit of combining multiple analytical platforms for metabolomics. These
are other recent examples where both NMR and GC-MS metabolomics datasets have been
integrated for applications in biomarker identification, food chemistry and plant physiology.
45–48
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To date, the majority of metabolomics studies have been self-limited to a single analytical
platform (Figure 1). This is despite the fact that NMR and MS (and other analytical
techniques) are highly complementary. Furthermore, existing workflows (Figure 2A) can
easily accommodate the inclusion of both techniques. Consequently, there is little to no
barrier to the broad adoption by the scientific community of a multi-analytical approach to
metabolomics. Importantly and as clearly demonstrated herein, combining NMR and MS
improves the coverage of the metabolome, increases the accuracy of metabolite assignments,
19–21 and provides redundant validation of metabolite changes. In fact, our results
demonstrate a limited overlap in the metabolites identified by both NMR and GC-MS. But,
most metabolites in common did exhibit consistent trends in relative concentration changes,
showcasing the robustness of the combined approach. Our results provide clear evidence that
both NMR and MS are equally valuable and necessary for metabolomics studies; and that
combining multiple analytical sources is essential to the future of metabolomics.
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Figure 1.

A summary of metabolomics publications in PubMed that only refer to NMR (yellow), to
GC-MS (blue) or to both GC-MS and NMR (grey).

Author Manuscript
Author Manuscript
J Proteome Res. Author manuscript; available in PMC 2019 November 02.

Bhinderwala et al.

Page 11

Author Manuscript
Figure 2.

Author Manuscript
Author Manuscript

(A) A workflow schematic showing the key steps in the combined NMR and GC-MS
analysis of the C. reinhardtii metabolome. Three biological replicates were prepared for each
group consisting of the untreated controls, WD30030 treated cells, and WD10784 treated
cells. A GC-MS spectrum and a 2D 1H-13C HSQC NMR spectrum were collected for each
biological replicate. (B) Multiblock PCA scores plot generated from the combined GC-MS
and 2D 1H-13C HSQC NMR datasets illustrating a distinct clustering for untreated controls
(■) and the WD30030 (■) and WD10784 (■) treated cells. Three biological replicates are
displayed per group, where each data point represents the combined GC-MS and 2D 1H-13C
HSQC NMR datasets plotted in PC-space. The ellipses represent a 95% confidence limit of
the normal distribution of each cluster. The associated dendrogram was derived from the
PCA scores plot and each node is annotated with a Mahalanobis distance-based p-value. The
separation between untreated controls and WD30030 (p-value 2.5 ×10−3) and WD10784 (pvalue 8.9 ×10−4), respectfully, is considered statistically significant (p < 0.05). The color
scheme for the dendrogram is the same as the scores plot.
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Figure 3.

Metabolic pathway summarizing the coverage of the C. reinhardtii metabolome (metabolites
of interest) from the combined application of NMR and GC-MS. Metabolites that were only
identified by NMR are colored blue. Metabolites that were only identified by GC-MS are
colored red. Metabolites identified by both methods are colored black, and metabolites not
identified are colored grey. The embedded Venn diagram identifies the total number of
metabolites of interest within these metabolic pathways that were identified by either NMR,
by GC-MS or by both techniques.
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Figure 4.

A comparison of the 22 relative metabolite concentration changes detected by NMR and
GC-MS. Metabolite changes resulting from treatment with WD30030 and WD10784 are
colored green or blue, respectively. The regression line fitted to the data exhibited a
correlation coefficient of R2 0.55 and confidence interval with a p-value < 0.001.
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